Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Placenta and Cord Blood Analyses

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Arkansas Children's Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT01104454
First received: April 14, 2010
Last updated: August 4, 2016
Last verified: August 2016
  Purpose
The purpose of this study is to standardize methods in collecting and processing placenta, umbilical cord and cord blood samples. Samples will be used to determine potential differences between normal weight, overweight and obese individuals.

Condition
Healthy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Placenta and Cord Blood Analyses

Further study details as provided by Arkansas Children's Hospital Research Institute:

Primary Outcome Measures:
  • Placenta, cord blood and umbilical analyses [ Time Frame: at delivery ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA
placenta, umbilical cord and cord blood

Enrollment: 60
Study Start Date: March 2010
Estimated Study Completion Date: September 2017
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Pregnant women who are at least 7 months pregnant
Criteria

Inclusion Criteria:

  • at least 7 months pregnant
  • 18 years of age or older

Exclusion Criteria:

  • underweight (BMI<18.5)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01104454

Locations
United States, Arkansas
Arkansas Children's Nutrition Center
Little Rock, Arkansas, United States, 72202
Sponsors and Collaborators
Arkansas Children's Hospital Research Institute
Investigators
Principal Investigator: Aline Andres, Ph.D. University of Arkansas
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Arkansas Children's Hospital Research Institute
ClinicalTrials.gov Identifier: NCT01104454     History of Changes
Other Study ID Numbers: 111576 
Study First Received: April 14, 2010
Last Updated: August 4, 2016
Health Authority: United States: Institutional Review Board

Keywords provided by Arkansas Children's Hospital Research Institute:
healthy pregnant women

ClinicalTrials.gov processed this record on September 30, 2016